Case Study: Oncological Management of a Patient with Papillary Thyroid Cancer

The following case study presents the management of
stage III Differentiated Thyroid Cancer (DTC) patient in an NHS
hospital in London, UK during period of 2004-2005.

• A. Taqaddas

• Differentiated Thyroid Cancer
• Oncological Management
• Papillary
• Thyroid Cancer
• Stage III.

[1] S. Sherman, "Thyroid Carcinoma,” The Lancet, 361, 2003, 501-511
[2] Cancer Research UK, "Thyroid Cancer Incidence statistics,” 2013.
Available at: http://www.cancerresearchuk.org/cancer-info/cancerstats/
types/thyroid/incidence/uk-thyroid-cancer-incidence-statistics#geog.
(Accessed 28/09/2014).
[3] O. Gimm, "Thyroid Cancer,” Cancer Letters, 163, 2001, 143-156.
[4] L. Vini, and C. Harmer, "Management of Thyroid Cancer,” Lancet
Oncology, 3, 2002, 407-14.
[5] C. Bomford, and I. Kunkler, Walter and Miller’s Textbook of
Radiotherapy: radiation physics, therapy and oncology, Edinburgh:
Churchill Livingstone, 2003.
[6] A. Shaha, and S. Patel, "Thyroid and Parathyroid Tumours,” in J. Shah,
(eds) Cancer of the Head and Neck. London: Hamilton, 2001.
[7] E. Mazzaferri, and R. Kloos, "Current Approaches to Primary Therapy
for Papillary and Follicular Thyroid Cancer,” The Journal of Clinical
Endocrinology & Metabolism, 86, 2001, 1447-1463.
[8] M. Curado, B. Edwards, H. Shin et al., "Cancer Incidence in Five
Continents, vol. 9 of IARC Scientific Publications,” No. 160, IARC,
Lyon, France, 2007.
[9] B. Busnardo, D. De Vido, "The epidemiology and etiology of
differentiated thyroid carcinoma,” Biomed & Pharmacother, 54, 2000,
322-6.
[10] T. McCarty, R. Vassilopoulou, & R. Lustig, "Thyroid and Parathyroid
Cancers,” in R. Pazdur, L. Coia, W. Hoskins, et al., (eds), Cancer
Management: A Multidisciplinary Approach. Medical, Surgical, &
Radiation Oncology. New York: PRR Inc, 2001.
[11] L. Wartofsky, "Papillary Carcinoma: Clinical Aspects,” in L. Wartofsky,
(eds.), Thyroid Cancer A comprehensive Guide to Clinical Management.
New Jersey: Humana Press Inc, 2000.
[12] M. Schlumberger, "Papillary and Follicular Thyroid Carcinoma,” The
New England Journal of Medicine, 338, 1998, 297-306.
[13] S. Moore, B. Haughey, "Surgical Treatment for Thyroid Cancer,”
AORN, 65,1997, 710-725
[14] M. Kouvaraki, J. Lee, S. Shapiro, S. Sherman, & B. Douglas,
"Preventable reoperations for persistent and recurrent papillary thyroid
carcinoma,” Surgery, 136, 2004, 1183-91.
[15] L. Zimmer, B. Mccook, C. Meltzer, M. Fukui, D. Bascom, C.
Snyderman, D. Townsend, and J. Johnson, "Combined Positron
emission tomography/computed tomography imaging of recurrent
thyroid cancer,” Otalaryngology-Head and Neck Surgery, 128, 2003,
178-84.
[16] H. Burch, "Papillary Thyroid Cancer: Prognosis,” in L. Wartofsky,
(eds.), Thyroid Cancer A comprehensive Guide to Clinical Management.
New Jersey: Humana Press Inc, 2000.
[17] J. Zidan, E. Hefer, G. Iosilevski, K. Drumea, M. Stein, A. Kuten, and O.
Israel, "Efficacy of I131 Ablation Therapy using Different doses as
determined by post operative thyroid scan uptake in patients with
differentiated thyroid cancer,” Int J. Radiation Oncology Biol. Phys, 59,
2004, 1330-1336
[18] O. Clark, "Surgical Approach to Papillary Carcinoma,” in L. Wartofsky,
(eds.), Thyroid Cancer A comprehensive Guide to Clinical Management.
New Jersey, Humana Press Inc, 2000.
[19] N. Esnaola, S. Cantor, S. Sherman, J. Lee, and D. Evans, "Optimal
treatment strategy in patients with papillary thyroid cancer: A decision
analysis,” Surgery, 130, 2001, 921-30.
[20] A. Phillips, J. Fenwick, U. Mallick, and P. Perros, "The Impact of
Clinical Guidelines on Surgical Management in Patients with Thyroid
Cancer,” Clinical Oncology, 15, 2003, 485-489
[21] K. Chao, C. Perez, and L. Brady, (eds) Radiation Oncology
Management Decisions. Philadelphia: Lippincott Williams & Wilkins,
2002.
[22] S. Chow, S. Law, W. Mendenhall, S. Au, P. Chan, T. Leung, C. Tong, I.
Wong, and W. Lau, "Papillary Thyroid Carcinoma: Prognostic Factors
and the role of Radioiodine and External Radiotherapy,” Int J.
Radiation Oncology Biol. Phys, 52, 2002, 784-795
[23] R. Mazzarotto, M. Cesaro, O. Lora, D. Rubello, D. Casara, and G. Sotti,
"The role of external beam radiotherapy in the management of
differentiated thyroid cancer,” Biomed & Pharmacother, 54, 2000, 345-
9
[24] D. Cooper, G. Doherty, B. Haugen, R. Kloos, S. Lee, S. Mandel et al.,
"Revised America Thyroid Association Management Guidlelines for
Patients with Thyroid Nodules and Differentiated Thyroid Cancer,”
Thyroid, 19, 2009, 1-48.
[25] D. Ford, S. Giridharan, C. McConkey., A. Hartley, C. Brammer, J.
Watkinson, et al., "External Beam Radiotherapy in the Management of
Differentiated Thyroid Cancer,” Clinical Oncology, 15, 2003, 337-341.
[26] M. Bauman, M. Saunders, and M. Joiner, "Modified Fractionation,” in
G. Steel, (eds), Basic Clinical Radiobiology. London: Arnold, 2002.
[27] C. Nutting, D. Convery, V. Cosgrove, C. Rowbottom, V. Louiza., C.
Harmer, D. Dearnley, and S. Webb S., "Improvements in target
Coverage and reduced spinal cord irradiation using Intensity-modulated
radiotherapy (IMRT) in patients with carcinoma of the thyroid gland,”
Radiotherapy and Oncology, 60, 2001, 173-180
[28] R. White, (2000) ‘Management of Papillary Thyroid Carcinoma:
External Radiation Therapy’ in L. Wartofsky, (ed.), Thyroid Cancer. A
comprehensive Guide to Clinical Management. New Jersey: Humana
Press Inc, 2000.
[29] P. Wilson, B. Millar, and Brierley, "The Management of Advanced
Thyroid Cancer,” Clinical Oncology, 16, 2004, 561-568.
[30] T. Kim, D. Yang, K. Jung, C. Kim, and M. Choi M., "Value of External
Irradiation for Locally Advanced Papillary Thyroid Cancer,”
International. Journal of Radiation Oncology Biology. Physics, 55,
2003, 1006-1012.